首页> 外国专利> procedure and means for simultaneous bestemning hormones human chorionic korionogonadotropin (hcg) and prolactin (prl)

procedure and means for simultaneous bestemning hormones human chorionic korionogonadotropin (hcg) and prolactin (prl)

机译:绒毛膜促性腺激素(hcg)和催乳激素(prl)同时最佳化激素的步骤和方法

摘要

Method for the determination of the hormone human chorionic gonadotropin (HCG), luteinizing hormone (LH), prolactin (PRL) and HCG- like material in an aqueous sample comprising contacting a highly specific receptor for these hormones with an aqueous sample to be tested, providing a means of indicating whether binding has taken place between the receptor and hormone possibly contained in the sample and observing the indicating means to determine the presence of the hormone in the sample. PRL may be determined separately or simultaneously with the HCG and LH. The receptor is a plasma membrane extract from the corpus luteum of an animal which possesses the receptor for HCG, LH, PRL and HCG-like material. Radioassay indicating means are preferred, according to which competitive protein binding between radioisotopically labeled hormone and hormone present in the sample is radiologically determined. The method has particular application to the determination to pregnancy in the human female.
机译:测定水性样品中人绒毛膜促性腺激素(HCG),黄体生成素(LH),催乳激素(PRL)和HCG样物质的激素的方法,包括使这些激素的高度特异性受体与待测水性样品接触,提供一种指示在受体和样品中可能包含的激素之间是否已经发生结合的方法,并观察指示剂以确定样品中激素的存在。 PRL可以与HCG和LH分开或同时确定。该受体是来自动物黄体的质膜提取物,其具有HCG,LH,PRL和HCG样物质的受体。优选放射测定指示手段,据此根据放射学确定放射性同位素标记的激素与样品中存在的激素之间的竞争性蛋白结合。该方法特别适用于确定人类女性的怀孕。

著录项

  • 公开/公告号SE437304B

    专利类型

  • 公开/公告日1985-02-18

    原文格式PDF

  • 申请/专利权人 CARTER-WALLACE INC;

    申请/专利号SE19790005898

  • 发明设计人 B B * SAXENA;

    申请日1979-07-05

  • 分类号G01N33/74;

  • 国家 SE

  • 入库时间 2022-08-22 08:11:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号